Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment

References

• Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88.
   PubMed Web of Science ®Google Scholar
• Mishra CB, Tiwari M, Supuran CT. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today? Med Res Rev 2020;40:2485–565.
   PubMed Web of Science ®Google Scholar
• Mincione F, Nocentini A, Supuran CT. Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opin Drug Discov 2021;16:1209–25.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension. Epxert Rev Neurother 2015;15:851–6.
   PubMed Web of Science ®Google Scholar
• Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022;32:833–47.
   PubMed Web of Science ®Google Scholar
• Swenson ER. Carbonic anhydrase inhibitros and high altitude ilnesses. Subcell Biochem 2014;75:361–86.
   PubMedGoogle Scholar
• Ciccone L, Cerri C, Nencetti S, Orlandini E. Carbonic anhydrase and epilepsy: state of the art and future perspectives. Molecules 2021;26:6380.
   PubMed Web of Science ®Google Scholar
• Buzás GM, Supuran CT. The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932–2015). J Enzyme Inhib Med Chem 2016;31:527–33.
   PubMed Web of Science ®Google Scholar
• Costa G, Carta F, Ambrosio FA, et al. A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors. Eur J Med Chem 2019;181:111565.
   PubMed Web of Science ®Google Scholar
• Wongboonsin J, Thongprayoon C, Bathini T, et al. Acetazolamide therapy in patients with heart failure: a meta-analysis. J Clin Med 2019;8:349.
   PubMedGoogle Scholar
• Moi D, Nocentini A, Deplano A, et al. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: synthesis and biological evaluation. Eur J Med Chem 2019;182:111638.
   PubMed Web of Science ®Google Scholar
• Bozdag M, Poli G, Angeli A, et al. N-aryl-N’-ureido-O-sulfamates: potent and selective inhibitors of the human carbonic anhydrase VII isoform with neuropathic pain relieving properties. Bioorg Chem 2019;89:103033.
   PubMed Web of Science ®Google Scholar
• Zaraei S-O, Abduelkarem AR, Anbar HS, et al. Sulfamates in drug design and discovery: pre-clinical and clinical investigations. Eur J Med Chem 2019;179:257–71.
   PubMed Web of Science ®Google Scholar
• Al-Warhi T, Sabt A, Elkaeed EB, Eldehna WM. Recent advancements of coumarin-based anticancer agents: an up-to-date review. Bioorg Chem 2020;103:104163.
   PubMed Web of Science ®Google Scholar
• Eldeeb AH, Abo-Ashour MF, Angeli A, et al. Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies. Eur J Med Chem 2021;221:113486.
   PubMed Web of Science ®Google Scholar
• Lomelino CL, Supuran CT, McKenna R. Non-classical inhibition of carbonic anhydrase. Int J Mol Sci 2016;17:1150.
   PubMed Web of Science ®Google Scholar
• Masini E, Carta F, Scozzafava A, Supuran CT. Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 2013;23:705–16.
   PubMed Web of Science ®Google Scholar
• A study of SLC-0111 and gemcitabine for metastatic pancreatic ductal cancer in subjects positive for CAIX (SLC-0111-17-01). [cited 2022 May 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT03450018.
   Google Scholar
• D'Ambrosio K, Carradori S, Monti SM, et al. Out of the active site binding pocket for carbonic anhydrase inhibitors. Chem Comm 2015;51:302–5.
   PubMed Web of Science ®Google Scholar
• Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem 2021;13:1935–7.
   PubMed Web of Science ®Google Scholar
• Cau Y, Vullo D, Mori M, et al. Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII. Molecules 2017;23:17.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Nocentini A, Elsayed ZM, et al. Benzofuran-based carboxylic acids as carbonic anhydrase inhibitors and antiproliferative agents against breast cancer. ACS Med Chem Letters 2020;11:1022–7.
   PubMed Web of Science ®Google Scholar
• Elimam DM, Elgazar AA, Bonardi A, et al. Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: design, synthesis and biological evaluation. Eur J Med Chem 2021;225:113800.
   PubMed Web of Science ®Google Scholar
• Alkhaldi AA, Al-Sanea MM, Nocentini A, et al. 3-Methylthiazolo [3, 2-a] benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: design, synthesis, biological and molecular modeling studies. Eur J Med Chem 2020;207:112745.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Abo-Ashour MF, Berrino E, et al. SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX. Bioorg Chem 2019;83:549–58.
   PubMed Web of Science ®Google Scholar
• Xu R-S, Yue L, Pan Y-J. Regioselective copper(I)-catalyzed C–H hydroxylation/C–S coupling: expedient construction of 2-(styrylthio)phenols. Tetrahedron 2012;68:5046–52.
   Web of Science ®Google Scholar
• Xu Z, Tice CM, Zhao W, et al. Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1. J Med Chem 2011;54:6050–62.
   PubMed Web of Science ®Google Scholar
• Glas C, Dietschreit JCB, Wössner N, et al. Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations. Eur J Med Chem 2020;206:112676.
   PubMed Web of Science ®Google Scholar
• Abo-Ashour MF, Eldehna WM, Nocentini A, et al. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: synthesis, in vitro biological evaluation and in silico insights. Eur J Med Chem 2019;184:111768.
   PubMed Web of Science ®Google Scholar
• Abdelrahman MA, Ibrahim HS, Nocentini A, et al. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: synthesis, biological and molecular dynamics analysis. Eur J Med Chem 2021;209:112897.
   PubMed Web of Science ®Google Scholar
• Elimam DM, Eldehna WM, Salem R, et al. Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors. Eur J Med Chem 2022;228:114008.
   PubMed Web of Science ®Google Scholar
• Abdelrahman MA, Eldehna WM, Nocentini A, et al. Novel benzofuran-based sulfonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation. J Enzyme Inhib Med Chem 2020;35:298–305.
   PubMed Web of Science ®Google Scholar
• Ibrahim HS, Abdelrahman MA, Nocentini A, et al. Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity. Bioorg Chem 2022;126:105888.
   PubMed Web of Science ®Google Scholar